Login / Signup

Toll-like receptors and IL-7 as potential biomarkers for immune-mediated necrotizing myopathies.

Cristina CappellettiRaffaella BrugnoniSilvia BonannoFrancesca AndreettaFranco SalernoEleonora CanioniGaetano Nicola Alfio VattemiPaola ToninRenato MantegazzaLorenzo Maggi
Published in: European journal of immunology (2023)
We aimed to verify whether the immune system may represent a source of potential biomarkers for the stratification of immune-mediated necrotizing myopathies (IMNMs) subtypes. A group of 22 patients diagnosed with IMNM [7 with autoantibodies against signal recognition particle (SRP) and 15 against 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR)] and 12 controls, were included. A significant preponderance of M1 macrophages was observed in both SRP+ and HMGCR+ muscle samples (p < 0.0001 in SRP+ and p = 0.0316 for HMGCR+), with higher values for SRP+ (p = 0.01). Despite the significant increase observed in the expression of TLR4 and all endosomal TLRs at protein level in IMNM muscle tissue, only TLR7 has been shown considerably up-regulated compared to controls at transcript level (p = 0.0026), whereas TLR9 was even decreased. (p = 0.0223). Within IMNM subgroups, TLR4 (p = 0.0116) mRNA was significantly increased in SRP+ compared to HMGCR+ patients. Within IMNM group, only IL-7 was differentially expressed between SRP+ and HMGCR+ patients, with higher values in SRP+ patients (p = 0.0468). Overall, innate immunity represents a key player in pathological mechanisms of IMNM. TLR4 and the inflammatory cytokine IL-7 represent potential immune biomarkers able to differentiate between SRP+ and HMGCR+ patients. This article is protected by copyright. All rights reserved.
Keyphrases